Long-term treatment with low-dose medicine in chronic childhood eczema: a double-blind two-stage randomized control trial

Table 4 Differences between groups A and B at stage 1 at T0-T8 and T9-T14

Variable	Group A T0-T8	Group B T0-T8	Difference between B-A groups	P value	Group A T9-T14 FU	Group B T9-T14 FU	Difference between B-A groups	p value
% decrease of the SCORAD index	41.5	53.8	12.3	0.014	19.9	21.9	2.0	0.77
Conventional therapy (months/person)	30	16	−14	0.074	30	9	−21	0.077
% of patients treated with steroids^a	32.1	23.1	−9.0	0.073	17.9	15.3	−2.6	0.15
% of patients treated with antihistamines^a	35.7	19.2	−16.5	0.003	32.1	11.5	−20.6	0.028

^aWe considered treated with steroids or antihistamines subjects that took at least one medication during the study. (FU: follow-up)

ISSN: 1824-7288